Document is current
Any future updates will be listed below
-
Authors
Rhodes, Joanna M.
Barrientos, Jacqueline C.
Rai, Kanti R.
- License Information
-
More Information
Article History
Accepted: 1 July 2022
First Online: 5 November 2022
Declarations
:
: Joanna M. Rhodes has received compensation from Abbvie, AstraZeneca, Genentech, Pharmacyclics, Beigene, Versatem, TG Therapeutics, Pharmacyclics, GenMab, SeaGen, and Morphosys for participation in advisory boards. Jacqueline Barrientos has received honoraria for consulting for Gilead, AstraZeneca, Janssen, Sandoz, Genentech, Bayer, and Celgene and research support from Pharmacyclics, Abbvie, AstraZeneca, and Gilead. Kanti R. Rai has no relevant conflicts of interest.
